Talecris Continues Global Expansion into Europe
Talecris Biotherapeutics GmbH established as a wholly-owned sales and service organization to serve more than 15 European countries
04-Dec-2006
- Germany
"Our expansion into Europe signifies another key milestone demonstrating the strategic growth we have planned for our company," said Alberto Martinez, M.D., CEO and President, Talecris Biotherapeutics. "We established Talecris Europe to deliver tailored sales and support services to our European customers, and our European leadership team brings the knowledge, experience and dedication to do exactly that."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
SPP100 (Tekturna/Rasilez) reduces left ventricular hypertrophy - Latest study reveals further potential benefits of renin inhibitor in heart disease
Go to page
Wittenfeld & Cornelius GbR - Bochum, Germany
Go to page
Scientists Most Value Sales Reps That Are Knowledgeable, Not Sales-Oriented
Go to page
Basilea's antibiotic BAL30072 shows activity against superbugs expressing the NDM-1 resistance factor
Go to page
Using nature as a model for low-friction bearings
Go to page
Scientists achieve first rewire of genetic switches
Go to page